Search | IOVS | ARVO Journals

Access Provided By:
MIT Libraries

Forgot password?

Create an Account

View

Showing 1 – 6 of 6

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract July 2018

The characteristics of diabetic retinopathy in ZDF type-2 diabetes rats

Akifumi Yamamoto; Osamu Sakai; Hideki Tokushige

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):5368.

ARVO Annual Meeting Abstract July 2018

Comparison between injectable anesthetic agents on transient cataract induced by general anesthesia in rats

ATSUKO YAMASHITA; Osamu Sakai; Hideki Tokushige

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):5653.

ARVO Annual Meeting Abstract June 2017

The influence of reversed light-dark cycle on circadian rhythm of intraocular pressure in mice

Rie Suzuki; Shu Matsushita; Osamu Sakai; Hideki Tokushige

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1066.

ARVO Annual Meeting Abstract September 2016

Development and analysis of a new rat glaucoma model

Ayumi Nakagawa; Osamu Sakai; Hideki Tokushige; Takashi Fujishiro; Makoto Aihara

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):2523.

ARVO Annual Meeting Abstract June 2013

Topical Bromfenac 0.1% suppresses Concanavalin-A Induced Blood Retinal Barrier Breakdown

Hiroaki Takahashi; Tetsuo Kida; Seiko Kozai; Hideki Tokushige

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):6363.

Glaucoma July 2007

Effects of Topical Administration of Y-39983, a Selective Rho-Associated Protein Kinase Inhibitor, on Ocular Tissues in Rabbits and Monkeys

PDF

Hideki Tokushige; Masaru Inatani; Shingo Nemoto; Hideyuki Sakaki; Koushirou Katayama; Masayoshi Uehata; Hidenobu Tanihara
TAGS: administration, topical, body tissue, cercopithecidae, eye, intraocular pressure, oryctolagus cuniculus, protein kinase inhibitor
Invest. Ophthalmol. Vis. Sci.. 2007; 48(7):3216-3222. https://doi.org/10.1167/iovs.05-1617

Advertisement